New guideline update on Neoadjuvant Chemotherapy for Ovarian Cancer – ASCO
Jan 24, 2025, 01:44

New guideline update on Neoadjuvant Chemotherapy for Ovarian Cancer – ASCO

ASCO shared a post on LinkedIn:

“Check out our new guideline update on Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer. These guideline recommendations suggest that patients with suspected stage III-IV EO should be evaluated by a gynecologic oncologist including CA-125, CT of the abdomen and pelvis, and chest imaging.

Read more.”